JP Morgan Private Capital, JP Morgan’s venture capital and growth equity investment team has held the final close of 270 Life Sciences Private Capital Fund I, above its $500m target.
LSPCF received commitments from institutional allocators, strategic corporate partners, family offices and HNWIs across North America, Europe, the Middle East and Asia, as well as JPMorgan Chase & Co. The fund close was led by CIO Stephen Squinto and Managing Partner Gaurav Gupta.
LSPCF invests in private biotechnology companies spanning cardiometabolic disease, oncology, immunology and genetic medicines.
Source:Private Equity Wire
Can’t stop reading? Read more
August Equity makes move into legal sector with Higgs investment
August Equity makes move into legal sector with Higgs investment August Equity has taken a stake...
Fund Friday: Top fundraising news in private equity
Fund Friday: Top fundraising news in private equity Neuberger Berman is approaching the first...
Blackstone set to win Warehouse REIT takeover after Tritax concedes
Blackstone set to win Warehouse REIT takeover after Tritax concedes Blackstone is poised to secure...
